Maravai LifeSciences supplies enabling products and services for biopharmaceutical research and manufacturing, including nucleic acid components, biologics safety testing reagents and related analytical tools. It became widely known for mRNA-related reagents used in vaccine and therapeutic development pipelines. Customers are primarily biotech and pharma companies as well as research laboratories.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 46.9 | — | -29.9 | — |
| Q2 2025 | 47.4 | — | -39.6 | — |
| Q3 2025 | 41.6 | — | -25.6 | — |
| Q4 2025 | 49.9 | — | -35.7 | — |
| Q1 2026 | 65.8 | 40.5% | -3.7 | — |
| Q2 2026 | 51.4 | 8.5% | -12.4 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Alarm.com Holdings, Inc. (ALRM), NetScout Systems, Inc. (NTCT), Alumis Inc. (ALMS), Upstart Holdings, Inc. (UPST), Adeia Inc. (ADEA), Alignment Healthcare, Inc. (ALHC)